{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:05:03Z","timestamp":1785855903170,"version":"3.56.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Administration of the optimal dose of levothyroxine (LT4) is crucial to restore euthyroidism after total thyroidectomy. An insufficient or excessive dosage may result in hypothyroidism or thyrotoxicosis, either one associated with a number of symptoms\/complications. Most literature regarding the LT4 dosage deals with the treatment of primary hypothyroidism, whereas a limited number of studies handle the issue of thyroxin replacement after total thyroidectomy. A literature review was performed focusing on all papers dealing with this topic within the last 15 years. Papers that reported a scheme to calculate the proper LT4 dose were collected and compared to set up a review exploring limits and drawbacks of LT4 replacement therapy in the wide population of patients who had undergone thyroidectomy. Most of the methods for monitoring and adjusting thyroid hormone replacement after thyroidectomy for benign disease use LT4 at an empirical dose of approximately 1.6 \u03bcg\/kg, with subsequent changes according to thyroid function test results and assessments of the patient\u2019s symptoms. Approximately 75% of patients require a dose adjustment, suggesting that factors other than body weight play a role in the determination of the proper LT4 dose. Hence, several schemes are reported in the literature for the proper initial dose of LT4. An inadequate level of thyroid hormone levels in these patients can be due to several factors. The most common ones that lead to the necessity of LT4 dose adjustments include lack of compliance, changes in LT4 formulation, dosage errors, increased serum levels of T4-binding globulin, body mass changes, and dietary habits. Moreover, concomitant ingestion of calcium supplements, ferrous sulfate, proton-pump inhibitors, bile acid sequestrants, and sucralfate might influence LT4 absorption and\/or metabolism. Furthermore, some gastrointestinal conditions and their treatments can contribute to suboptimal LT4 performance by altering gastric acidity and thereby reducing its bioavailability, particularly in the solid form. Beyond the classic tablet form, new formulations of LT4, such as a soft gel capsule and an oral solution, recently became available. The liquid formulation is supposed to overcome the food and beverages interference with absorption of LT4 tablets.<\/jats:p>","DOI":"10.3389\/fendo.2020.626268","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T06:18:21Z","timestamp":1611901101000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Levothyroxine Therapy in Thyrodectomized Patients"],"prefix":"10.3389","volume":"11","author":[{"given":"Paolo","family":"Miccoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Materazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s40261-016-0462-3","article-title":"The Economic Impact of Levothyroxine Dose Adjustments: the CONTROL HE Study","volume":"37","author":"Ernst","year":"2017","journal-title":"Clin Drug Investig"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2010.03940.x","article-title":"Predicting thyroxine requirements following total thyroidectomy","volume":"74","author":"Mistry","year":"2011","journal-title":"Clin Trial Clin Endocrinol (Oxf)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2019.06.025","article-title":"Optimizing Levothyroxine Dose Adjustment After Thyroidectomy With a Decision Tree","volume":"244","author":"Chen","year":"2019","journal-title":"J Surg Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-013-0137-2","article-title":"Influence of high-normal serum TSH levels on major cardiovascular risk factors and Visceral Adiposity Index in euthyroid type 2 diabetic subjects","volume":"47","author":"Giandalia","year":"2014","journal-title":"Endocrine"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcte.2019.100189","article-title":"A minimum of two years of undertreated primary hypothyroidism, as a T result of drug-induced malabsorption of L-thyroxine, may have metabolic and cardiovascular consequences","volume":"16","author":"Benvenga","year":"2019","journal-title":"J Clin Transl Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00168","article-title":"Gastrointestinal Malabsorption of Thyroxine","volume":"40","author":"Virili","year":"2019","journal-title":"Endocr Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2012.12.002","article-title":"Using body mass index to predict optimal thyroid dosing after thyroidectomy","volume":"216","author":"Ojomo","year":"2013","journal-title":"J Am Coll Surg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0002","DOI":"10.5041\/RMMJ.10229","article-title":"Thyroid Hormone Replacement in Patients Following Thyroidectomy for Thyroid Cancer","volume":"7","author":"Hannoush","year":"2016","journal-title":"Rambam Maimonides Med J"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00233","article-title":"Ulcerative Colitis as a Novel Cause of Increased Need for Levothyroxine","volume":"10","author":"Virili","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12020-019-02049-x","article-title":"Novel thyroxine formulations: a further step toward precision medicine","volume":"66","author":"Virili","year":"2019","journal-title":"Endocrine"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1242-4","article-title":"Treatment pattern and frequency of serum TSH measurement in users of different levothyroxine formulations: a population-based study during the years 2009-2015","volume":"58","author":"Ferrara","year":"2017","journal-title":"Endocrine"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/lio2.186","article-title":"Oral L-thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study","volume":"3","author":"Fallahi","year":"2018","journal-title":"Laryngoscope Invest Otolaryngol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7053959","article-title":"TSH Variability of Patients Affected by Differentiated Thyroid Cancer Treated with Levothyroxine Liquid Solution or Tablet Form","volume":"2017","author":"Cappelli","year":"2017","journal-title":"Int J Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s12020-019-02051-3","article-title":"Thyroid hormone therapy in differentiated thyroid cancer","volume":"66","author":"Grani","year":"2019","journal-title":"Endocrine"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"B16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/bjs.5157","article-title":"Optimization of thyroxine replacement therapy after total or near-total thyroidectomy for benign thyroid disease","volume":"93","author":"Olubowale","year":"2006","journal-title":"Br J Surg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0314","article-title":"Individually-tailored thyroxine requirement in the same patients before and after thyroidectomy: a longitudinal study","volume":"173","author":"Del Duca","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2012.10.015","article-title":"Levothyroxine replacement dosage determination after thyroidectomy","volume":"205","author":"Jin","year":"2013","journal-title":"Am J Surg"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0111","article-title":"A new strategy to estimate levothyroxine requirement after total thyroidectomy for benign thyroid disease","volume":"24","author":"Di Donna","year":"2014","journal-title":"Thyroid"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2015.10.005","article-title":"Prospective Intervention of a Novel Levothyroxine Dosing Protocol Based on Body Mass Index after Thyroidectomy","volume":"222","author":"Elfenbein","year":"2016","journal-title":"J Am Coll Surg"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2018.04.097","article-title":"The optimal dosing scheme for levothyroxine after thyroidectomy: A comprehensive comparison and evaluation","volume":"165","author":"Zaborek","year":"2019","journal-title":"Surgery"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-019-05523-4","article-title":"Optimal levothyroxine dose in post-total thyroidectomy patients: a prediction model for initial dose titration","volume":"276","author":"Al-Dhahri","year":"2019","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1709318","article-title":"Subclinical Hyperthyroidism","volume":"378","author":"Biondi","year":"2018","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-018-0884-2","article-title":"Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies","volume":"41","author":"Pacini","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/JC.2015-1346","article-title":"Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012","volume":"100","author":"Carhill","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ19-0094","article-title":"Thyroid function related symptoms during levothyroxine monotherapy in athyreotic patients","volume":"66","author":"Ito","year":"2019","journal-title":"Endocr J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1244-2","article-title":"Undertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine","volume":"56","author":"Benvenga","year":"2017","journal-title":"Endocrine"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-014-0082-9","article-title":"Comparison between liquid and tablet levothyroxine formulations in patients treated through enteral feeding tube","volume":"37","author":"Pirola","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1384535","article-title":"Utility of a Liquid Formulation of Levo-thyroxine in Differentiated Thyroid Cancer Patients","volume":"65","author":"Giusti","year":"2015","journal-title":"Drug Res (Stuttg)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9043450","article-title":"Thyroid Hormone Profile in Patients Ingesting Soft Gel Capsule or Liquid Levothyroxine Formulations with Breakfast","volume":"2016","author":"Cappelli","year":"2016","journal-title":"Int J Endocrinol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-1003-9","article-title":"Comparative study between the effects of replacement therapy with liquid and tablet formulations of levothyroxine on mood states, self-perceived psychological well-being and thyroid hormone profile in recently thyroidectomized patients","volume":"55","author":"Lombardi","year":"2017","journal-title":"Endocrine"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1311-8","article-title":"Is levothyroxine requirement the same for tablet and soft gel formulations","volume":"59","author":"Di Donna","year":"2018","journal-title":"Endocrine"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1367-5","article-title":"Treatment of refractory and severe hypothyroidism with sublingual levothyroxine in liquid formulation","volume":"60","author":"Peirce","year":"2018","journal-title":"Endocrine"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.626268\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T06:18:23Z","timestamp":1611901103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.626268\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":33,"alternative-id":["10.3389\/fendo.2020.626268"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.626268","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,29]]},"article-number":"626268"}}